RenalytixAI Initiates Clinical Validation Study of AI-Enabled KidneyIntelX(TM) for Diagnosing Fast-Progressing Kidney Disease; Validation study to assess approximately 5,000 patients with participation from a multi-center group of leading U.S. investigato

Press/Media

Period23 Jan 2019

Media coverage

1

Media coverage

  • TitleRenalytixAI Initiates Clinical Validation Study of AI-Enabled KidneyIntelX(TM) for Diagnosing Fast-Progressing Kidney Disease; Validation study to assess approximately 5,000 patients with participation from a multi-center group of leading U.S. investigato
    Media name/outletPR Newswire
    Country/TerritoryUnited States
    Date23/01/19
    PersonsBarbara Murphy, Steven Coca, Michael Donovan